Wealthspire Advisors (New York)’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Sell
1,165
-365
-24% -$89.3K ﹤0.01% 776
2025
Q4
$388K Buy
1,530
+365
+31% +$91.7K ﹤0.01% 700
2025
Q3
$288K Sell
1,165
-406
-26% -$97.2K ﹤0.01% 687
2025
Q2
$377K Buy
1,571
+373
+31% +$86.8K ﹤0.01% 607
2025
Q1
$272K Buy
+1,198
New +$263K ﹤0.01% 667
2024
Q4
Sell
-1,204
Closed -$292K 837
2024
Q3
$292K Buy
+1,204
New +$282K ﹤0.01% 626
2021
Q4
Sell
-2,834
Closed -$579K 619
2021
Q3
$579K Buy
+2,834
New +$606K 0.01% 331

Other funds holding STE

Wealthspire Advisors (New York)'s STE Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Steris (STE) stake by 24% in Q1 2026, selling an estimated $89.3K and leaving 1,165 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Wealthspire Advisors (New York) first reported a position in STE in Q3 2021 and has held it in 7 quarters since. The position peaked at $579K in Q3 2021. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Wealthspire Advisors (New York) held 1,165 shares of Steris worth $258K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 365 Steris shares in Q1 2026, an estimated $89.3K.
  • Steris made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #776 holding.
  • Wealthspire Advisors (New York) first reported a position in Steris in Q3 2021 and has held it in 7 quarters since.
  • Wealthspire Advisors (New York)'s Steris position peaked at $579K in Q3 2021.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.